Effects of chronic methylphenidate on cocaine self-administration under a progressive-ratio schedule of reinforcement in rhesus monkeys

Journal of Pharmacology and Experimental Therapeutics

Volumn 345, Issue 3, 2013, Pages 374-382

  Czoty, Paul W ^a   Martelle, Susan E ^a   Gould, Robert W ^a   Nader, Michael A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC DRUG ADMINISTRATION; COCAINE DEPENDENCE; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EXPOSURE; DRUG SELF ADMINISTRATION; LOCOMOTION; MAINTENANCE DRUG DOSE; MALE; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; RHESUS MONKEY; TREATMENT DURATION;

ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; COCAINE-RELATED DISORDERS; DEXTROAMPHETAMINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FOOD; INJECTIONS, INTRAVENOUS; MACACA MULATTA; MALE; METHYLPHENIDATE; REINFORCEMENT (PSYCHOLOGY); REINFORCEMENT SCHEDULE; SELF ADMINISTRATION;

EID: 84878070553     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.113.204321     Document Type: Article

References (47)

1. Andersen SL, Arvanitogiannis A, Pliakas AM, LeBlanc C, and Carlezon WA, Jr (2002) Altered responsiveness to cocaine in rats exposed to methylphenidate during development. Nat Neurosci 5:13-14.
2. Ator NA and Griffiths RR (2003) Principles of drug abuse liability assessment in laboratory animals. Drug Alcohol Depend 70 (Suppl)S55-S72.
3. Banks ML, Blough BE, Fennell TR, Snyder RW, and Negus SS (2012) Role of phenmetrazine as an active metabolite of phendimetrazine: Evidence from studies of drug discrimination and pharmacokinetics in rhesus monkeys. Drug Alcohol Depend DOI: [published ahead of print].
4. Bergman J, Madras BK, Johnson SE, and Spealman RD (1989) Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J Pharmacol Exp Ther 251:150-155.
5. Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Kotarski M, and Spencer T (2010) A randomized, 3-phase, 34-week, double-blind, long-term efficacy study of osmotic-release oral system-methylphenidate in adults with attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 30:549-553.
6. Bouffard R, Hechtman L, Minde K, and Iaboni-Kassab F (2003) The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder. Can J Psychiatry 48:546-554.
7. Carroll FI, Howell LL, and Kuhar MJ (1999) Pharmacotherapies for treatment of cocaine abuse: Preclinical aspects. J Med Chem 42:2721-2736.
8. Chiodo KA, Läck CM, and Roberts DC (2008) Cocaine self-administration reinforced on a progressive ratio schedule decreases with continuous D-amphetamine treatment in rats. Psychopharmacology (Berl) 200:465-473.
9. Chiodo KA and Roberts DC (2009) Decreased reinforcing effects of cocaine following 2 weeks of continuous D-amphetamine treatment in rats. Psychopharmacology (Berl) 206:447-456.
10. Collins SL, Levin FR, Foltin RW, Kleber HD, and Evans SM (2006) Response to cocaine, alone and in combination with methylphenidate, in cocaine abusers with ADHD. Drug Alcohol Depend 82:158-167.
11. Czoty PW, Gould RW, Martelle JL, and Nader MA (2011) Prolonged attenuation of the reinforcing strength of cocaine by chronic d-amphetamine in rhesus monkeys. Neuropsychopharmacology 36:539-547.
12. Czoty PW, Martelle JL, and Nader MA (2006) Influence of abstinence and conditions of cocaine access on the reinforcing strength of cocaine in nonhuman primates. Drug Alcohol Depend 85:213-220.
13. Czoty PW, Martelle JL, and Nader MA (2010) Effects of chronic d-amphetamine administration on the reinforcing strength of cocaine in rhesus monkeys. Psychopharmacology (Berl) 209:375-382.
14. Gill KE, Pierre PJ, Daunais J, Bennett AJ, Martelle S, Gage HD, Swanson JM, Nader MA, and Porrino LJ (2012) Chronic treatment with extended release methylphenidate does not alter dopamine systems or increase vulnerability for cocaine selfadministration: A study in nonhuman primates. Neuropsychopharmacology 37: 2555-2565.
15. Glowa JR and Fantegrossi WE (1997) Effects of dopaminergic drugs on food-and cocaine-maintained responding. IV: Continuous cocaine infusions. Drug Alcohol Depend 45:71-79.
16. Glowa JR, Wojnicki F, Matecka D, Bacher J, Mansbach R, Balster R, and Rice K (1995a) Effects of dopamine reuptake inhibitors on food-and cocaine-maintained responding: I. Dependence on unit dose of cocaine. Exp Clin Psychopharmacol 3: 219-231.
17. Glowa JR, Wojnicki FHE, Matecka D, and Rice KC (1995b) Effects of dopamine reuptake inhibitors on food-and cocaine-maintained responding: II. Comparisons with other drugs and repeated administrations. Exp Clin Psychopharmacol 3:232-239.
18. Grabowski J, Roache JD, Schmitz JM, Rhoades H, Creson D, and Korszun A (1997) Replacement medication for cocaine dependence: Methylphenidate. J Clin Psychopharmacol 17:485-488.
19. Grabowski J, Shearer J, Merrill J, and Negus SS (2004) Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addict Behav 29: 1439-1464.
20. Herin DV, Rush CR, and Grabowski J (2010) Agonist-like pharmacotherapy for stimulant dependence: Preclinical, human laboratory, and clinical studies. Ann N Y Acad Sci 1187:76-100.
21. Hiranita T, Soto PL, Newman AH, and Katz JL (2009) Assessment of reinforcing effects of benztropine analogs and their effects on cocaine self-administration in rats: Comparisons with monoamine uptake inhibitors. J Pharmacol Exp Ther 329: 677-686.
22. Holmes VF (1995) Medical use of psychostimulants: An overview. Int J Psychiatry Med 25:1-19.
23. Howell LL and Kimmel HL (2008) Monoamine transporters and psychostimulant addiction. Biochem Pharmacol 75:196-217.
24. Kleven MS and Woolverton WL (1993) Effects of three monoamine uptake inhibitors on behavior maintained by cocaine or food presentation in rhesus monkeys. Drug Alcohol Depend 31:149-158.
25. Levin FR, Evans SM, Brooks DJ, and Garawi F (2007) Treatment of cocaine dependent treatment seekers with adult ADHD: Double-blind comparison of methylphenidate and placebo. Drug Alcohol Depend 87:20-29.
26. Lile JA and Nader MA (2003) The abuse liability and therapeutic potential of drugs evaluated for cocaine addiction as predicted by animal models. Curr Neuropharmacol 1:21-46.
27. Mariani JJ and Levin FR (2012) Psychostimulant treatment of cocaine dependence. Psychiatr Clin North Am 35:425-439.
28. Mello NK and Negus SS (1996) Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14:375-424.
29. Negus SS (2003) Rapid assessment of choice between cocaine and food in rhesus monkeys: Effects of environmental manipulations and treatment with d-amphetamine and flupenthixol. Neuropsychopharmacology 28:919-931.
30. Negus SS, Baumann MH, Rothman RB, Mello NK, and Blough BE (2009a) Selective suppression of cocaine-versus food-maintained responding by monoamine releasers in rhesus monkeys: Benzylpiperazine, (1)phenmetrazine, and 4-benzylpiperidine. J Pharmacol Exp Ther 329:272-281.
31. Negus SS, Brandt MR, and Mello NK (1999) Effects of the long-acting monoamine reuptake inhibitor indatraline on cocaine self-administration in rhesus monkeys. J Pharmacol Exp Ther 291:60-69.
32. Negus SS and Mello NK (2003) Effects of chronic d-amphetamine treatment on cocaine-and food-maintained responding under a second-order schedule in rhesus monkeys. Drug Alcohol Depend 70:39-52.
33. Negus SS, Mello NK, Blough BE, Baumann MH, and Rothman RB (2007) Monoamine releasers with varying selectivity for dopamine/norepinephrine versus serotonin release as candidate "agonist" medications for cocaine dependence: Studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeys. J Pharmacol Exp Ther 320:627-636.
34. Negus SS, Mello NK, Kimmel HL, Howell LL, and Carroll FI (2009b) Effects of the monoamine uptake inhibitors RTI-112 and RTI-113 on cocaine-and food-maintained responding in rhesus monkeys. Pharmacol Biochem Behav 91:333-338.
35. Platt DM, Rowlett JK, and Spealman RD (2002) Behavioral effects of cocaine and dopaminergic strategies for preclinical medication development. Psychopharmacology (Berl) 163:265-282.
36. Richardson NR and Roberts DCS (1996) Progressive ratio schedules in drug selfadministration studies in rats: A method to evaluate reinforcing efficacy. J Neurosci Methods 66:1-11.
37. Rothman RB, Blough BE, Woolverton WL, Anderson KG, Negus SS, Mello NK, Roth BL, and Baumann MH (2005) Development of a rationally designed, low abuse potential, biogenic amine releaser that suppresses cocaine self-administration. J Pharmacol Exp Ther 313:1361-1369.
38. Rothman RB, Katsnelson M, Vu N, Partilla JS, Dersch CM, Blough BE, and Baumann MH (2002) Interaction of the anorectic medication, phendimetrazine, and its metabolites with monoamine transporters in rat brain. Eur J Pharmacol 447: 51-57.
39. Rush CR and Stoops WW (2012) Agonist replacement therapy for cocaine dependence: A translational review. Future Med Chem 4:245-265.
40. Schubiner H, Saules KK, Arfken CL, Johanson CE, Schuster CR, Lockhart N, Edwards A, Donlin J, and Pihlgren E (2002) Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Exp Clin Psychopharmacol 10:286-294.
41. Somoza EC, Winhusen TM, Bridge TP, Rotrosen JP, Vanderburg DG, Harrer JM, Mezinskis JP, Montgomery MA, Ciraulo DA, and Wulsin LR, et al. (2004) An open-label pilot study of methylphenidate in the treatment of cocaine dependent patients with adult attention deficit/hyperactivity disorder. J Addict Dis 23: 77-92.
42. Stafford D, LeSage MG, Rice KC, and Glowa JR (2001) A comparison of cocaine, GBR 12909, and phentermine self-administration by rhesus monkeys on a progressiveratio schedule. Drug Alcohol Depend 62:41-47.
43. Thanos PK, Michaelides M, Benveniste H, Wang GJ, and Volkow ND (2007) Effects of chronic oral methylphenidate on cocaine self-administration and striatal dopamine D2 receptors in rodents. Pharmacol Biochem Behav 87:426-433.
44. Thomsen M, Barrett AC, Negus SS, and Caine SB (2013) Cocaine versus food choice procedure in rats: Environmental manipulations and effects of amphetamine.J Exp Anal Behav 99:211-233.
45. Vocci F and Ling W (2005) Medications development: Successes and challenges. Pharmacol Ther 108:94-108.
46. Volkow ND, Wang GJ, Fowler JS, Fischman M, Foltin R, Abumrad NN, Gatley SJ, Logan J, Wong C, and Gifford A, et al. (1999) Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain. Life Sci 65:PL7-PL12.
47. Winhusen TM, Somoza E, Singal BM, Harrer J, Apparaju S, Mezinskis J, Desai P, Elkashef A, Chiang CN, and Horn P (2006) Methylphenidate and cocaine: A placebo-controlled drug interaction study. Pharmacol Biochem Behav 85:29-38.